Upregulation of the angiogenic factor heparin affin regulatory peptide by progesterone in rat uterus.
Heparin affin regulatory peptide (HARP), also named pleiotropin, is a secreted polypeptide that belongs to a new family of heparin-binding growth/differentiation factors. In this study, we investigated the expression and distribution of HARP mRNA and protein in rat uterus. Semi-quantitative reverse transcriptase PCR experiments showed variations in HARP mRNA levels throughout the estrous cycle, with a maximum during diestrus, pointing to hormonal regulation of HARP mRNA expression. Uterine expression of HARP mRNA was studied in ovariectomized animals treated with 17 beta-estradiol, progesterone alone or progesterone and RU486. In these experiments, progesterone upregulated HARP mRNA expression. Induction was observed 6 h after progesterone injection and was inhibited by RU486 treatment. In contrast, after 17 beta-estradiol injection, a slight decrease in HARP mRNA expression was observed. In situ hybridization studies with digoxigenin-labeled DNA probe revealed that HARP mRNA was present in smooth muscle cells of both myometrium and blood vessels and also in endothelial cells from endometrium. Immunohistochemical studies showed that HARP expression was not limited to cells that expressed HARP mRNA, but also occurred in both the luminal and glandular epithelium even though its transcript was never detected. We conclude that HARP may mediate the effects of progesterone on the homeostasis and vascularization of uterine tissue.
Milhiet
P E
PE
Laboratoire de recherche sur la Croissance Cellulaire, la Réparation et la Régénération tissulaires (CRRET), CNRS UPRESA 7053, Université Paris XII, Créteil, France.
Vacherot
F
F
Caruelle
J P
JP
Barritault
D
D
Caruelle
D
D
Courty
J
J
D000818:Animals; D001808:Blood Vessels / Q000378:metabolism*; D002352:Carrier Proteins / Q000235:genetics / Q000378:metabolism*; D016207:Cytokines / Q000235:genetics / Q000378:metabolism*; D004848:Epithelium / Q000378:metabolism; D004958:Estradiol / Q000494:pharmacology; D004971:Estrus; D005260:Female; D015870:Gene Expression / Q000187:drug effects; D006133:Growth Substances; D006727:Hormone Antagonists / Q000494:pharmacology; D007150:Immunohistochemistry; D017403:In Situ Hybridization; D015735:Mifepristone / Q000494:pharmacology; D008934:Mitogens / Q000235:genetics / Q000378:metabolism*; D009130:Muscle, Smooth / Q000378:metabolism; D010052:Ovariectomy; D016133:Polymerase Chain Reaction; D011374:Progesterone / Q000037:antagonists & inhibitors / Q000494:pharmacology; D012333:RNA, Messenger / Q000032:analysis; D051381:Rats; D011919:Rats, Inbred Strains; D014599:Uterus / Q000187:drug effects / Q000378:metabolism*
D002352:Carrier Proteins; D016207:Cytokines; D006133:Growth Substances; D006727:Hormone Antagonists; D008934:Mitogens; D012333:RNA, Messenger; C066845:pleiotrophin; D015735:Mifepristone; D011374:Progesterone; D004958:Estradiol